| Introduction: Cardiovascular diseases
(CVDs) are recognized as the leading cause
of mortality worldwide. The increasing
prevalence of such disease demand novel
therapeutic and diagnostic approaches to
overcome associated clinical/social issues.
Recent advances in nanotechnology and
biological sciences have provided intriguing
insights to employ targeted nanosystems (NSs)
to the desired location as multifunctional
system for diagnosis, imaging and therapy of various diseases, including CVDs. Nanomedicines,
as novel tool for improved drug delivery, imaging, and diagnosis, have shown great promise in
combating the CVDs.
Methods: In the current study, we intend to review the most recent studies on the nano-based
strategies for improved management of the CVDs.
Results: A cascade of biological events can result in the formation of atheromatous plaque and
arterial stenosis, which need to be controlled. Recent studies have shown that nanomedicines can
provide unique therapeutic benefits in the diagnosis and treatment of atherosclerosis.
Conclusion: Despite some limitations, nanomedicines hold considerable potentials in the
prevention, diagnosis, and treatment of various formidable diseases such as atherosclerosis. They
offer various benefits, including maximal therapeutic effects with minimal side effects, amenable
physicochemical properties such as surface modifications, and multifunctionality. Therefore, it
is strongly envisioned that by the targeted drug delivery to the atherosclerotic lesions and plaque
using nanomedicines, the onset and progression of CVDs can be efficiently managedin comparsion
with the currently used classical treatment modalities. |